USSTOCK.TODAY
Regular Market
Log in Sign up

Sanofi raises 2026 guidance as Q3 sales reach 14.4 billion euros

The Motley Fool +1 · ·by G4L

SNY Sanofi ADR
$48.12 +2.30%
View chart & analysis →
  1. 1Sanofi recorded total Q3 sales of 14.4 billion euros, with double-digit growth in sales and earnings per share.
  2. 2Sanofi raised its 2026 guidance following a 14.3% year-over-year increase in total Q3 sales.
  3. 3Sanofi reaffirmed its commitment to three core areas: immunology, rare diseases, and vaccines.

So what's the key point?

Sanofi achieved 14.4 billion euros in sales during the third quarter, showing significant growth. With sales up 14.3%, the company also raised its targets through 2026.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Nurix Therapeutics Inc. Shares Plunge on Sanofi Program Discontinuation Investing.com +2 · 6d agoRegeneron Beats Q3 Revenue and Profit Estimates, Shares Rise 4% Investing.com +1 · Oct 30Sanofi and ScionX Bio enter strategic collaboration to develop mRNA therapeutics Pharmaceutical Technology +1 · Oct 21
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news